The diagnosis and treatment of protozoan diseases /
The Diagnosis and Treatment of Protozoan Diseases discusses about major protozoan diseases such as Malaria, Leishmaniasis, etc., including clinically minor protozoan diseases.
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Format: | eBook |
| Language: | English |
| Published: |
London :
Academic Press,
2024.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- Front Cover
- The Diagnosis and Treatment of Protozoan Diseases
- The Diagnosis and Treatment of Protozoan Diseases
- Copyright
- Dedication
- Contents
- Contributors
- Preface
- 1
- Brief introduction to infectious diseases
- Infectious diseases
- Protozoan diseases
- Epidemiology of protozoan diseases
- References
- 2
- Malaria
- Introduction
- Global burden
- Life cycle and differences between different species
- Plasmodium falciparum
- Plasmodium vivax
- Plasmodium malariae
- Plasmodium ovale
- Plasmodium knowlesi
- Diagnosis
- Classical diagnostic techniques versus advance techniques
- Classical diagnostic techniques
- Microscopic and conventional analytical techniques
- Rapid detection approaches
- Molecular techniques
- Noninvasive diagnosis
- Advanced techniques
- New challenges in diagnostic/diagnostic marker
- Treatment
- Drugs
- Chloroquine
- Artemisinin
- Artemisinin-based combination therapies
- Amodiaquine
- Mefloquine
- Transmission blocking drugs
- Atovaquone
- Proguanil
- Antibiotics
- New-generation antimalarial drugs
- Vaccine
- Preerythrocytic vaccines
- Transmission-blocking vaccines
- Whole parasite vaccines
- Novel strategies
- Drug resistance
- Quinolines
- Antifolates
- Atovaquone
- Artemisinin
- Multidrug resistance
- Urgency
- Efficacy, safety, and effectiveness
- Summary
- References
- 3
- Leishmaniasis
- Introduction
- Global burden
- Cutaneous leishmaniasis
- Mucocutaneous leishmaniasis
- Visceral leishmaniasis
- Post-kala-azar leishmaniasis
- Life cycle
- Diagnosis
- Conventional diagnosis
- Parasitological methods
- Immunological methods
- Molecular methods
- Recent advancement
- Fluorescence-activated cell sorting
- Proteomics
- Advanced molecular methods
- Nanodiagnosis
- Treatment of leishmaniasis.
- Recent developments in the treatment of leishmaniasis
- Multidrug therapy
- Drug repurposing
- Nanotechnology
- Host-directed therapy
- Antimicrobial peptides
- Vaccine
- First-generation vaccines
- Whole-killed vaccines
- Fractionated Leishmania antigens
- Second-generation vaccines
- Genetically modified parasite vaccines
- Third-generation vaccines
- New strategy of vaccines
- Vaccine antigen delivery systems
- Chimeric vaccines
- Nonpathogen Leishmania spp. in vaccination
- Viral-like particle vaccines
- mRNA vaccines
- Conclusions and future perspectives
- References
- 4
- Trypanosomiasis
- Introduction
- life cycle and differences between different species
- Diagnosis
- Treatment
- Drug resistance
- Urgency
- Summary
- References
- 5
- Trichomoniasis
- Introduction
- Epidemiology
- Morphology
- Transmission
- Clinical features
- Pathogenesis
- Pathologic features
- Life cycle and differences between different species
- Trichomonas-related human and nonhuman species
- Diagnosis
- Classical diagnostic techniques versus advanced techniques
- Microscopy
- Culture
- Advanced techniques for the diagnosis of trichomoniasis
- Antibody-based technique
- Molecular methods
- New challenges in diagnostic/diagnostic marker
- Treatment
- Drugs: advancement in drug discovery
- Vaccine: advancement in vaccine discovery
- Drug resistance
- Advancement in drug resistance to encounter the new drug resistance development
- Urgency
- Efficacy, safety, and effectiveness
- Tinidazole
- Ornidazole
- Secnidazole
- Nimorazole
- Carnidazole
- Summary
- References
- 6
- Giardiasis
- Introduction
- Life cycle of Giardia duodenalis
- Species variation
- Diagnosis of giardiasis
- Classical versus advanced diagnostic techniques
- Inherent limitations in diagnostic methods
- Conventional microscopic methods.
- Immunological assays
- Detection of nucleic acid
- Treatment of giardiasis
- Clinically used drugs
- Drugs resistance
- Advancement in therapeutic and prophylactic agents
- Advancement in drug discovery
- Vaccine and the advancement of vaccine discovery
- Limitations and advances in vaccine development
- Vaccine candidates
- Peptide-based vaccine candidates for giardiasis
- The way forward
- References
- 7
- Balantidiasis
- Introduction
- Taxonomy
- Hosts
- Morphology
- Transmission
- Epidemiology
- Pathogenesis and clinical manifestations
- Life cycle and differences between species
- Diagnosis
- Classical diagnostic techniques versus advanced techniques
- New challenges in diagnostic/diagnostic marker
- Treatment
- Drugs
- References
- 8
- Protozoan diseases having less global burden
- Babesiosis
- Epidemiology
- Life cycle
- Diagnosis and treatment
- Prevention and control
- Naegleriasis
- Epidemiology
- Life cycle
- Diagnosis and treatment
- Prevention and control
- Acanthamoebiasis
- Epidemiology
- Life cycle
- Diagnosis and treatment
- Cystoisosporiasis
- Epidemiology
- Life cycle
- Diagnosis and treatment
- Blastocystosis
- Epidemiology
- Life cycle
- Diagnosis and treatment
- Dientamoebiasis
- Epidemiology
- Life cycle
- Diagnosis and treatment
- Prevention and control
- References
- 9
- Summary of advancement in protozoan disease diagnosis and treatment
- Introduction
- Treatment of protozoan diseases
- Diagnosis of protozoan diseases
- Vaccines for protozoan diseases
- References
- Index
- Back Cover.